|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kintara Therapeutics, Inc (KTRA) |
|
|
$0.08 0.00 (0.00%) as of 4:30 Fri 11/11
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,680,000 |
| Market
Cap: |
141.29(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0841 - $0.0841 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoffman Robert |
President, CEO, and CFO |
• • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
59,800 |
68,902 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
240,087 |
246,905 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
240,087 |
277,273 |
|
- |
|
| Hoffman Robert |
President and CEO |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
400,145 |
455,145 |
|
- |
|
| Hoffman Robert |
President and CEO |
• • – |
2022-02-15 |
4 |
B |
$0.47 |
$25,795 |
D/D |
55,000 |
55,000 |
2.81 |
-34% |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2021-12-08 |
4 |
B |
$0.68 |
$19,430 |
D/D |
28,700 |
37,186 |
2.74 |
-59% |
|
| Zarrabian Saiid |
Head of Strategic Partnerships |
• • – |
2021-12-07 |
4 |
B |
$0.64 |
$24,298 |
D/D |
38,109 |
55,500 |
2.81 |
-55% |
|
| Zarrabian Saiid |
Head of Strategic Partnerships |
• • – |
2021-12-06 |
4 |
B |
$0.59 |
$7,018 |
D/D |
11,891 |
17,391 |
2.81 |
-52% |
|
| Douglass Laura L. |
Director |
– • – |
2021-11-22 |
4 |
B |
$0.74 |
$2,227 |
D/D |
3,000 |
3,000 |
2.31 |
-46% |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
325 |
1,566 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3 |
1,241 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
6,818 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6 |
6,068 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
938 |
8,486 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
7,548 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,540 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,238 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17 |
6,062 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,230 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17 |
6,045 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,518 |
|
- |
|
| Brown Dennis M |
Chief Scientific Officer |
• – – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17 |
6,028 |
|
- |
|
| Praill Scott |
Chief Financial Officer |
• – – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
22 |
7,496 |
|
- |
|
| Toth Robert Joseph Jr |
Director |
– • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
1,222 |
|
- |
|
| Liatos John |
SVP, Business Development |
• • – |
2020-08-19 |
4 |
B |
$0.00 |
$0 |
D/D |
196,750 |
196,750 |
2.73 |
-4% |
|
165 Records found
|
|
Page 1 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
